Showing results (1-10 of 452) with videos related to
Sort By:
Pageof 46
Expert Review of Neurotherapeutics|June 10, 2011
Cell-based therapies for Parkinson's diseaseSean C Dyson, Roger A BarkerDisease Models & Mechanisms|August 3, 2014
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's diseaseJing-Wei Zhao, Sean C Dyson, Christina Kriegel, et al.Cell Stem Cell|December 18, 2014
Developing stem cell therapies for Parkinson's disease: waiting until the time is rightRoger A BarkerNature Medicine|July 3, 2019
Designing stem-cell-based dopamine cell replacement trials for Parkinson's diseaseRoger A Barker, Parkinsonism & Related Disorders|January 20, 2010
Parkinson's disease and growth factors - are they the answer?Roger A BarkerRegenerative Medicine|December 6, 2012
Stem cells and neurodegenerative diseases: where is it all going?Roger A BarkerNeuropsychological Rehabilitation|December 15, 2005
The neurological assessment of patients in vegetative and minimally conscious statesRoger A BarkerDegenerative Neurological and Neuromuscular Disease|March 21, 2019
Stem cells and regenerative therapies for Parkinson's diseaseKrista Farrell, Roger A BarkerFrontiers in Integrative Neuroscience|December 14, 2011
The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A ReviewRuwani Wijeyekoon, Roger A BarkerNeurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Immune problems in central nervous system cell therapyRoger A Barker, Håkan WidnerPageof 46